© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 06, 2021
A discussion on what it means for a biosimilar to have “interchangeability” status and its potential impact on biosimilar adoption in clinical practice.
A panel of experts in neuroendocrine tumors review the challenges in the management of patients based on the site of the tumor.
Experts address barriers to overcome regarding naloxone prescribing, dispensing, and utilization that they have seen in the community.
Multidisciplinary expert panel share perspectives on stigmatization and normalization of the conversation about naloxone between clinicians and patients.
April 05, 2021
With their content ranging from pharmacy references in pop culture to more clinical discussions of specific drugs, the Let's Pharmonize podcast hosts have learned to balance the rigors of school with their biweekly podcast.
Ted Karkus, CEO of ProPhase Labs, discusses the differences between saliva COVID-19 tests and nasal swab COVID-19 tests and their different uses in clinical practice.
April 02, 2021
Estela Trimino, PharmD, BCPS, leads a discussion on changes in barcoding practices to address infection control challenges caused by COVID-19.
Michael Epshteyn, PharmD, MSM, discusses some of the infection control challenges caused by COVID-19, such as the procurement of personal protective equipment (PPE).
Estela Trimino, PharmD, BCPS, discusses the use and impact of premixed IV solutions and drug reconstitution systems compared to compounded IV products.
Megan May, PharmD, BCOP, reviews the authorization process for treatment options for the management of NETs.